Shin akwai iyakokin shekaru don yin rigakafin cutar sankarar mahaifa?
An fara gabatar da rigakafin HPV na farko don hana cutar sankarar mahaifa a kasuwa. Kafin wannan, babbar hanyar hana cutar sankarar mahaifa ita ce ta hanyar binciken mahaifa.
Kudin CCTV a baya sun ruwaito cewa allurar rigakafin ita ce "Sirius" na kamfanin hada magunguna na Biritaniya GlaxoSmithKline - farashin bivalent na kwayar cutar kwayar cuta guda biyu (HPV-16 da HPV-18) wanda zai iya haifar da cutar sankarar mahaifa da kuma allurar rigakafi mafi hadari.
Game da bayanin cewa mafi kyaun shekaru na allurar rigakafin yana da shekaru 9 zuwa 25, Zhang Youzhong, mataimakin darektan sashen kula da cututtukan mata da Oncology, asibitin Qilu na jami'ar Shandong, ya ce a wata hira da Qilu Maraice News cewa ko da ya gama Shekaru 25, idan bai kamu da kwayar HPV ba, Ko kuma bai kamu da kwayar cutar da muka ambata a sama ba kuma ana iya yin allura. China’s annual ciwon sankarar mahaifa cases account for more than 28% of the world’s, and it is one of the most common malignant tumors for women. Globally, cervical cancer is also the third most common cancer among women aged 15 to 44.
Gwani: Akwai yanayi uku da suka wuce shekaru 25. Hakanan zaka iya kiran
official website na Gwamnatin Abinci da Magunguna don nuna cewa HPV Sinawa ne kira kwayar cutar papilloma ta mutum. Mafi yawan sanannun nau'ikan HPV fiye da 100 a halin yanzu "ƙananan haɗari ne" kuma ba sa haɗuwa da cutar sankarar mahaifa, amma 14 daga cikinsu an lasafta su a matsayin "haɗari mai haɗari" kuma biyu daga cikin haɗarin haɗari masu haɗari (HPV-16 Type da HPV- Nau'in 18) na iya haifar da kusan kashi 70% na cutar sankarar mahaifa.
Shekaru mafi kyau don yin allurar rigakafin bivalent "Cirius" wannan lokacin yana da shekaru 9 zuwa 25. Yawancin 'yan yanar gizo masu yawan shekaru sun nuna nadama. Shin mutane sama da shekaru 25 zasu iya yin rigakafin?
A ranar 3 ga watan Agusta, Zhang Youzhong, mataimakin darektan sashen kula da cututtukan cututtukan mata a asibitin Qilu na jami’ar Shandong, ya fada a wata hira da Qilu Maraice News cewa, shekaru 9-25 kawai za a iya fahimta a matsayin mafi kyawun shekarun yin allurar. A zahiri, akwai lokuta uku inda har yanzu ana iya yin wannan allurar: na ɗaya shi ne cewa duk da cewa ya wuce shekaru 25, bai kamu da cutar ta HPV ba; dayan kuma shi ne cewa ya kamu da kwayar cutar ta HPV, amma ba ta kamuwa da kwayar cutar ta HPV iri biyu, 16, 18; Na uku shi ne cewa duk da cewa cutar ta HPV ta kamu da cutar kuma sanadiyyar cututtukan sankarar mahaifa sun faru, ya warke ya zama hadari.
Dangane da bayanan jama'a da Hukumar Abinci da Magunguna ta jihar ta bayar, kamuwa da cutar ta HPV sun fi zama ruwan dare tsakanin mata. Bayanai sun nuna cewa a wani mataki na rayuwa, mata 4 cikin 5 za su kamu da cutar. Idan ka kamu da cutar ta HPV mai matukar hadari, to yana iya ci gaba zuwa mummunan rauni na mahaifa ko ma ya zama sankarar mahaifa.
Kwayar cutar ta HPV galibi ana yada ta ne ta hanyar saduwa da jima'i, kuma ana iya kamuwa da ita ta hanyar mu'amala kai tsaye: misali, bayan ka taba wani abu mai dauke da HPV a hannunka, kana iya kawo kwayar cutar a cikin sassan halittar haihuwa yayin yin wanka ko wanka; ko kuma idan kwayar haihuwar ta kamu da cutar ta HPV Abubuwa kamar tawul din wanka na iya kamuwa.
Ana tsammanin za a jera alurar riga kafi huɗu a cikin zamanin.
A cewar CCTV Financial Reports, babban mahaifa maganin ciwon daji ya kasu kashi biyu, hudu, da farashin tara. A wannan karon an amince da sayar da shi a cikin Ƙasar Mainland. Ita ce GlaxoSmithKline ta HPV rigakafin bivalent.
Qiao Youlin, darektan dakin gwaje-gwajen cututtukan sankara na kwalejin koyon aikin likitanci ta kasar Sin, ya fada a wata hira da gidan talabijin na CCTV cewa, a watan Mayu na wannan shekarar, allurar rigakafin ta hudu (bisa dogaro da allurar rigakafin bivalent, an yi niyya kan kwayoyin cutar HPV biyu, da kuma shekarun da ya dace yana da shekaru 20 zuwa 45) Jiha ta amince da shi kuma ana tsammanin za a jera shi a ƙarshen shekara.
Dangane da lokacin da jama'a za su iya amfani da allurar rigakafin tara-valent, Qiao Youlin ta ce allurar rigakafin tara ba ta riga ta shiga gwajin asibiti ba, kuma lokacin da ake sa ran ya “dade sosai.”
Shin za a haɗa rigakafin HPV a cikin inshorar lafiya a nan gaba? Zhao Fanghui, mataimakin darekta, farfesa kuma malamin digirin digirgir na sashen nazarin cututtukan sankara, asibitin sankara, kwalejin kimiya ta likitanci ta kasar Sin, ya yi imanin cewa da wuya a rage farashin allurar ta hanyar gasar kasuwa, sannan a rufe shi ta inshorar lafiya.
Game da allurar rigakafin cutar sankarar mahaifa, Hukumar Abinci da Magunguna ta Jihar ta tunatar da cewa tunda akwai ƙananan ƙananan ƙwayoyin cuta na HPV sama da 10 masu haɗarin cutar sankarar mahaifa, kuma ana yin allurar rigakafin ne kawai ga wasu daga cikinsu, koda kuwa an yi musu rigakafin, ya kamata har yanzu a koyaushe Nunawa.
